SP3, yes, if not a lot more. I think it may well get back to $2 within a month, if not sooner. This SP fell off a 'GFC style' cliff for no fundamental reason at all in my view.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025